News Search Results
Jan 21, 2026, 08:00 ET Variant Bio Appoints Craig T. Basson, MD, PhD, to Advance Genomics-Driven Clinical Programs
President of R&D. Dr. Basson brings more than 25 years of leadership experience across academic medicine, global pharmaceutical development, and biotechnology, with deep expertise in cardiovascular and metabolic disease, human genetics, and translational science.
More news about: Variant Bio
Jan 21, 2026, 07:00 ET L-Nutra Secures $36.5M Investment from Mubadala, Raising Series D Proceeds to $83.5M and Accelerating Global Expansion of Its Longevity and Medical Nutrition Therapies
Ali Abdulla, Executive Director of UAE Clusters, at Mubadala's UAE Investment Platform. "In addition to Mubadala Bio, our biomanufacturing and biotechnology national champion, we continue to execute Mubadala's life sciences strategy by investing in innovative solutions that advance human health and longevity.
More news about: L-Nutra Inc.
Jan 21, 2026, 06:44 ET Veterinary Diagnostics Market to Expand at 10.75% CAGR by 2035 | Discover Strategic Opportunities with Vantage Market Research
market research reports and actionable intelligence across healthcare, biotechnology, and advanced cell therapies. Our globally recognized insights empower stakeholders to make informed decisions, anticipate trends, and capitalize
More news about: Vantage Market Research
Jan 21, 2026, 03:00 ET Infinitopes Expands Seed Financing to $35 Million to Accelerate Clinical Development of Precision Cancer Vaccine
OXFORD, England, Jan. 21, 2026 /PRNewswire/ -- Infinitopes, a clinical-stage cancer vaccine biotechnology company, today announced the successful completion of the second close of its seed financing round, securing an additional $15.4 million and bringing
More news about: Infinitopes
Jan 20, 2026, 19:15 ET Insilico Medicine and Hygtia Therapeutics Enter New Global Strategic Collaboration to Co-Develop Novel Brain Penetrant NLRP3 Inhibitor for CNS Diseases treatment
CAMBRIDGE, Mass., Jan. 20, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", HKEX: 3696), a clinical-stage biotechnology company powered by generative artificial intelligence (AI), and Hygtia Therapeutics Co., Ltd., (Hygtia Therapeutics), today announced a co-development
More news about: Insilico Medicine
Jan 20, 2026, 19:00 ET Rakuten Medical Expands Academic Access to IR700 Dye Through Fee-Only Provision, Greater Publication Freedom and Expanded IP & Commercialization Opportunities
discoveriesSAN DIEGO, Jan. 20, 2026 /PRNewswire/ -- Rakuten Medical, Inc., a global biotechnology company developing and commercializing Alluminox® platform-based photoimmunotherapy, today announced that it will provide IRDye® 700DX N-hydroxy
More news about: Rakuten Medical, Inc.
Jan 20, 2026, 16:05 ET Halozyme to Host Investor Conference Call to Provide Updated Financial Guidance and Business Update
than one million patient lives through ten commercialized products across over 100 global markets and is licensed to leading pharmaceutical and biotechnology companies including Roche, Takeda, Pfizer, Janssen, AbbVie, Eli Lilly, Bristol-Myers Squibb, argenx, ViiV Healthcare, Chugai Pharmaceutical, Acumen
More news about: Halozyme Therapeutics, Inc.
Jan 20, 2026, 13:53 ET Olatec Therapeutics Presented Preclinical Evidence of Disease-Modifying Activity with Dapansutrile in its Parkinson's Studies
Olatec Therapeutics, Inc. ("Olatec"), a clinical stage biotechnology company leading the development of specific NLRP3 inhibitors, presented preclinical data at The Michael J. Fox Foundation (MJFF) Parkinson's Disease
More news about: Olatec Therapeutics, Inc.
Jan 20, 2026, 13:35 ET The Inner Circle Acknowledges Dr. David Thrasher as a Pinnacle Professional for Leadership in Healthcare and Public Service
Speaker Nathaniel Ledbetter's longevity task force. His influence helped foster partnerships with institutions such as the HudsonAlpha Institute for Biotechnology.Lilly's investment reflects Alabama's advanced manufacturing strength and the relationships forged during the crisis—relationships that positioned
More news about: The Inner Circle
Jan 20, 2026, 12:53 ET Rubin Rudman Attorney Stephanie Addeo Named an Up & Coming Lawyer by Massachusetts Lawyers Weekly
Rubin Rudman serves national and international companies, including large public companies and closely held businesses; real estate developers; biotechnology, pharmaceutical and medical device makers; regulated industries, public entities and municipalities; insurance companies and their insureds; educational
More news about: Rubin Rudman
Jan 20, 2026, 12:51 ET Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035
NSE: SYNGENE, ISIN: INE 398R01022) is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. Syngene's team of over 8,200 employees including 5,600 scientists, brings
More news about: Syngene International
Jan 20, 2026, 12:41 ET Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035
NSE: SYNGENE, ISIN: INE 398R01022) is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. Syngene's team of over 8,200 employees including 5,600 scientists, brings
More news about: Syngene International
Jan 20, 2026, 10:51 ET Intravascular Temperature Management Market Surges to USD 2.5 Billion by 2033, Propelled by 8.9% CAGR - Verified Market Reports®
Devices, Temperature Control Devices), By Application (Pharmaceutical Storage, Vaccine Transportation), By End-User (Pharmaceutical Companies, Biotechnology Firms), By Technology (Wireless Monitoring Systems, Internet of Things (IoT) Integrated Solutions), By Feature (Real-Time Monitoring, Alarm Systems
More news about: Verified Market Reports
Jan 20, 2026, 10:46 ET New Jersey's Emerging Medtech Ecosystem Showcased Through Edge Medical Ventures Event at Liberty Science Center
more of a connected ecosystem, diversified model," said John Coelho, Senior Advisor, Life Sciences Strategic Innovation Centers, NJEDA. "Biotechnology is heavily dependent on medtech, and we see tremendous opportunity in both moving to the state."Edge is a Qualified Venture Fund of NJEDA's
More news about: Edge Medical Ventures
Jan 20, 2026, 10:30 ET Nucleic Acid Isolation and Purification Market worth $10.99 billion by 2030 | MarketsandMarkets™
2024.the market is segmented into hospitals & diagnostic centers, academic and government research institutes, pharmaceutical & biotechnology companies, CROs, and others. In 2024, hospitals and diagnostic centers held the largest revenue share because they run high daily volumes of molecular
More news about: MarketsandMarkets
Jan 20, 2026, 10:13 ET Sleep Clinical Trial Published in Nature Scientific Reports: 'GABA Factory' Probiotic LP815® Improves Sleep and Reduces Stress
functional biotics that improve quality of life through clinically proven innovation.About Verb BioticsVerb Biotics is a B2B biotechnology company that delivers clinically validated microbiome ingredients to functional food, beverage, dietary supplement, and companion animal brands.
More news about: Verb Biotics
Jan 20, 2026, 10:00 ET Think Bioscience Raises $55M in Oversubscribed Series A
BOULDER, Colo., Jan. 20, 2026 /PRNewswire/ -- Think Bioscience ("Think Bio"), a biotechnology company focused on unlocking elusive drug targets, has raised $55M in an oversubscribed Series A. The round was led by Regeneron Ventures, Innovation
More news about: Think Bioscience
Jan 20, 2026, 10:00 ET Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughput Kinase Inhibitor Screening
SwiftFluo® TR-FRET kits accelerate kinase drug discovery.About Sino BiologicalFounded in 2007, Sino Biological is a global biotechnology company specializing in high-quality recombinant proteins, antibodies, and CRO services. Serving researchers in over 90 countries, Sino Biological
More news about: Sino Biological, Inc.
Jan 20, 2026, 10:00 ET Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughput Kinase Inhibitor Screening
SwiftFluo® TR-FRET kits accelerate kinase drug discovery.About Sino BiologicalFounded in 2007, Sino Biological is a global biotechnology company specializing in high-quality recombinant proteins, antibodies, and CRO services. Serving researchers in over 90 countries, Sino Biological
More news about: Sino Biological, Inc.
Jan 20, 2026, 10:00 ET MedSync Corp Appoints Major General (Ret.) Elder Granger, MD as Chief Medical Officer, Caps Transformational 2025 Growth in Value-Based Care
Product Officer: Healthcare leader with experience across four startups and two mid-sized MedTech and high-tech companies. He holds a Master's in Biotechnology Entrepreneurship from Johns Hopkins University and a Product Management specialization from University of Pennsylvania, is a patent holder and clinical
More news about: MedSync Corp
Jan 20, 2026, 10:00 ET Abcam joins the Innovative Health Initiative LIGAND-AI project to advance artificial intelligence (AI)-driven drug discovery through open science
we can offer unparalleled breadth and depth of expertise and solutions to our customers.Together with Danaher's other businesses across Biotechnology, Diagnostics and Life Sciences, we unlock the transformative potential of cutting-edge science and technology to improve billions of lives every
More news about: Abcam
Jan 20, 2026, 09:01 ET ProGro BIO Expands Rhizol Platform with Two New Microbial Products
biologically advanced products that are practical, efficient, and grower focused.About ProGro BIOProGro BIO is an agricultural biotechnology company focused on improving soil health, nutrient efficiency, and crop performance through advanced microbial technologies. The company's Rhizol
More news about: ProGro BIO Inc.
Jan 20, 2026, 09:00 ET K18 Taps GlamBOT Director Cole Walliser for Global Hair Flip Challenge and Guinness World Record™ Attempt for a Cause
mission is to liberate the freedom of self expression through healthy hair. Its patented K18PEPTIDE™, is a breakthrough ingredient developed from biotechnology that is revolutionizing the industry. Unlike traditional treatments, the K18PEPTIDE™ works at the molecular level, mimicking the natural structure
More news about: K18 Biomimetic Hairscience
Jan 20, 2026, 08:00 ET CannaLean Biotechs Announces Positive Completion of First-in-Human Feasibility Study of Its Novel CBD-Based Lipid-Lowering Therapy
TEL AVIV, Israel, Jan. 20, 2026 /PRNewswire/ -- CannaLean Biotechs Ltd., a clinical-stage biotechnology company developing a patented cannabidiol–chitosan (CBD–CHT) formulation for dyslipidemia, today announced the successful completion of its first-in-human
More news about: CannaLean Biotechs Ltd.
Jan 20, 2026, 08:00 ET Ouro Medicines Receives U.S. FDA Fast Track Designation for Gamgertamig in Immune Thrombocytopenia and Autoimmune Hemolytic Anemia
SOUTH SAN FRANCISCO, Calif., Jan. 20, 2026 /PRNewswire/ -- Ouro Medicines, a clinical stage biotechnology company developing immune reset therapeutics for people living with chronic, immune-mediated diseases, today announced that gamgertamig (OM336),
More news about: Ouro Medicines